Title

Top Five Gene Therapy Stories of 2019

UMMS Affiliation

Department of Pediatrics; Horae Gene Therapy Center

Publication Date

2019-01-10

Document Type

Editorial

Disciplines

Genetics and Genomics | Therapeutics

Abstract

The continued rapid progress of human gene and cell therapy in the latter half of the 2010s is fueled by the maturation of gene and cell therapy platforms, improvements in manufacturing capabilities, and an investment climate in the United States and Europe that has been very favorable to biotechnology and pharmaceutical industries engaged in gene therapy product development. Many of these factors are likely to continue in 2019, although some of them may bear further examination. Given what is known in late 2018, the following predictions are put forward for consideration.

DOI of Published Version

10.1089/hum.2018.29080.trf

Source

Hum Gene Ther. 2019 Jan;30(1):1-2. doi: 10.1089/hum.2018.29080.trf. Link to article on publisher's site

Journal/Book/Conference Title

Human gene therapy

Related Resources

Link to Article in PubMed

PubMed ID

30628861

Share

COinS